Private equity firm DCP Capital will purchase a minority interest in the Canadian consumer health brand Jamieson Wellness’s Chinese operations and make a preferred share investment in the company, according to a company announcement.
DCP will inject approximately $35 million in exchange for a 33.3% share in the company’s Chinese operations. Separately, it will subscribe to $75 million worth of preferred shares in the Jamieson brand itself. Both transactions are expected to close concurrently in the second quarter of 2023, the company statement said.
